Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure ...

Renal denervation offers a potentially transformative and minimally invasive option for treating hypertension. With this ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., ...

The move aims to broaden interventional cardiology therapies with ultrasound-based renal denervation therapy to treat ...

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

Autoimmune diseases make the immune system attack healthy tissues. These can affect organs like kidneys, leading to ...

This acquisition could bring Boston Scientific into the now-competitive renal denervation (RDN) space. Recor Medical received a landmark FDA nod for its Paradise ultrasound-based RDN system in ...

What Is Renal Cell Carcinoma? It's the most common type of kidney cancer. Although it’s a serious disease, finding and treating it early makes it more likely that you’ll be cured. No matter ...

Boston Scientific is acquiring Israeli medtech firm SoniVie for up to $540 million. The deal includes an upfront payment of ...